{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:30:53Z","timestamp":1787653853738,"version":"build-2736575974"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100012351","name":"Mitsubishi Tanabe Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012351","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To clarify relevant proteins and clinical characteristics of a phenotype of IgG4-related disease (IgG4-RD) with lymphadenopathy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We enrolled patients newly diagnosed with IgG4-RD in our department between January 2000 and June 2018 and performed proteomic analysis to measure serum concentrations of 1305 proteins. We extracted proteins overexpressed in patients with IgG4-RD with lymphadenopathy by comparing between those with lymphadenopathy, those without lymphadenopathy and healthy controls. We further reviewed all the patients with IgG4-RD in our institution and investigated the characteristics and prognosis of the patients with IgG4-RD with lymphadenopathy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eighty-five patients with IgG4-RD were enrolled, of which, 55% had lymphadenopathy. Proteomic analysis in 31 patients with IgG4-RD and 6 healthy controls revealed that eotaxin-3 was a potential serum biomarker in the patients with lymphadenopathy versus those without lymphadenopathy and healthy controls. A cohort of 85 patients with IgG4-RD demonstrated that patients with lymphadenopathy showed a significantly higher serum IgG4, IgG4:IgG ratio, IgG4-RD responder index and eosinophilia (P\u2009&amp;lt;\u20090.001 for all), irrelevant of the extent to which organ involvement developed. Patients with lymphadenopathy treated with glucocorticoid alone relapsed with significantly higher rates than those without lymphadenopathy (P\u2009=\u20090.03).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Lymphadenopathy in IgG4-RD represents a phenotype associated with high disease activities, eosinophilia and relapsing disease. Eotaxin-3 is a novel biomarker related to IgG4-RD with lymphadenopathy.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa648","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T13:03:46Z","timestamp":1600347826000},"page":"967-975","source":"Crossref","is-referenced-by-count":27,"title":["Lymphadenopathy in IgG4-related disease: a phenotype of severe activity and poor prognosis, with eotaxin-3 as a new biomarker"],"prefix":"10.1093","volume":"60","author":[{"given":"Satoshi","family":"Takanashi","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9720-0698","authenticated-orcid":false,"given":"Takanori","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5075-8977","authenticated-orcid":false,"given":"Mitsuhiro","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekata","family":"Yasuoka","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"},{"name":"Division of Rheumatology, Department of Internal Medicine, Fujita Health University School of Medicine, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Yoshimoto","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyasu","family":"Seki","sequence":"additional","affiliation":[{"name":"Research Unit\/Immunology & Inflammation Sohyaku, Mitsubishi Tanabe Parma Corporation, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Sugahara","sequence":"additional","affiliation":[{"name":"Research Unit\/Immunology & Inflammation Sohyaku, Mitsubishi Tanabe Parma Corporation, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Chiba","sequence":"additional","affiliation":[{"name":"Research Unit\/Immunology & Inflammation Sohyaku, Mitsubishi Tanabe Parma Corporation, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2646-5765","authenticated-orcid":false,"given":"Yuko","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,7]]},"reference":[{"key":"2021020119155176200_keaa648-B1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"2021020119155176200_keaa648-B2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"2021020119155176200_keaa648-B3","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.39209","article-title":"Number of circulating follicular helper 2 T cells correlates with IgG4 and interleukin-4 levels and plasmablast numbers in IgG4-related disease","volume":"67","author":"Akiyama","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2021020119155176200_keaa648-B4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13075-016-1064-4","article-title":"Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease","volume":"18","author":"Akiyama","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2021020119155176200_keaa648-B5","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","article-title":"Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients","volume":"54","author":"Lin","year":"2015","journal-title":"Rheumatology (Oxford"},{"key":"2021020119155176200_keaa648-B6","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","article-title":"IgG4-related disease: a cross-sectional study of 114 cases","volume":"34","author":"Zen","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"2021020119155176200_keaa648-B7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.semdp.2012.07.001","article-title":"Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity","volume":"29","author":"Cheuk","year":"2012","journal-title":"Semin Diagn Pathol"},{"key":"2021020119155176200_keaa648-B8","doi-asserted-by":"crossref","first-page":"e000432","DOI":"10.1136\/rmdopen-2017-000432","article-title":"Distinct features distinguishing IgG4-related disease from multicentric Castleman\u2019s disease","volume":"3","author":"Sasaki","year":"2017","journal-title":"RMD Open"},{"key":"2021020119155176200_keaa648-B9","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/modpathol.2012.54","article-title":"Association between IgG4-related disease and progressively transformed germinal centers of lymph nodes","volume":"25","author":"Sato","year":"2012","journal-title":"Mod Pathol"},{"key":"2021020119155176200_keaa648-B10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13000-016-0493-3","article-title":"Diagnostic dilemma of IgG4-related primary localized cervical lymphadenopathy associated with aberrant IL-6 expression level","volume":"11","author":"Nakamura","year":"2016","journal-title":"Diagn Pathol"},{"key":"2021020119155176200_keaa648-B11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"2021020119155176200_keaa648-B12","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1038\/mtna.2014.49","article-title":"Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents","volume":"3","author":"Rohloff","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"key":"2021020119155176200_keaa648-B13","doi-asserted-by":"crossref","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PLoS One"},{"key":"2021020119155176200_keaa648-B14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13075-016-1006-1","article-title":"Identification of definitive serum biomarkers associated with disease activity in primary Sj\u00f6gren\u2019s syndrome","volume":"18","author":"Nishikawa","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2021020119155176200_keaa648-B15","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1074\/mcp.M113.032136","article-title":"Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscan\u2122) platform","volume":"13","author":"Webber","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"2021020119155176200_keaa648-B16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/PAS.0b013e318157c068","article-title":"Lymphadenopathy of IgG4-related sclerosing disease","volume":"32","author":"Cheuk","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"2021020119155176200_keaa648-B17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021020119155176200_keaa648-B18","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1034\/j.1398-9995.2001.t01-1-00001.x","article-title":"A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force","volume":"56","author":"Johansson","year":"2001","journal-title":"Allergy"},{"key":"2021020119155176200_keaa648-B19","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","article-title":"Predictors of disease relapse in IgG4-related disease following rituximab","volume":"55","author":"Wallace","year":"2016","journal-title":"Rheumatology (Oxford"},{"key":"2021020119155176200_keaa648-B20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.semarthrit.2019.06.018","article-title":"Biomarkers in IgG4-related disease: a systematic review","volume":"50","author":"Tang","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2021020119155176200_keaa648-B21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ajg.2016.40","article-title":"Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort","volume":"111","author":"Culver","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"2021020119155176200_keaa648-B22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/259408","article-title":"Development of an IgG4-RD responder index","volume":"2012","author":"Carruthers","year":"2012","journal-title":"Int J Rheumatol"},{"key":"2021020119155176200_keaa648-B23","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.163.3.1602","article-title":"A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils","volume":"163","author":"Shinkai","year":"1999","journal-title":"J Immunol"},{"key":"2021020119155176200_keaa648-B24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1189\/jlb.0212074","article-title":"CCL26\/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11\/eotaxin-1 and CCL24\/eotaxin-2","volume":"94","author":"Provost","year":"2013","journal-title":"J Leukoc Biol"},{"key":"2021020119155176200_keaa648-B25","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/rheumatology\/ken033","article-title":"Eotaxin-3 is involved in Churg-Strauss syndrome\u2014a serum marker closely correlating with disease activity","volume":"47","author":"Polzer","year":"2008","journal-title":"Rheumatology (Oxford"},{"key":"2021020119155176200_keaa648-B26","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jaci.2015.02.039","article-title":"Correlation between CCL26 production by human bronchial epithelial cells and airway eosinophils: involvement in patients with severe eosinophilic asthma","volume":"136","author":"Larose","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2021020119155176200_keaa648-B27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fimmu.2019.00074","article-title":"Eotaxin-3 as a plasma biomarker for mucosal eosinophil infiltration in chronic rhinosinusitis","volume":"10","author":"Yamada","year":"2019","journal-title":"Front Immunol"},{"key":"2021020119155176200_keaa648-B28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cyto.2018.05.009","article-title":"Interleukin-4 contributes to the shift of balance of IgG subclasses toward IgG4 in IgG4-related disease","volume":"110","author":"Akiyama","year":"2018","journal-title":"Cytokine"},{"key":"2021020119155176200_keaa648-B29","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.20090313","article-title":"IL-4-producing CD4+ T cells in reactive lymph nodes during helminth infection are T follicular helper cells","volume":"206","author":"King","year":"2009","journal-title":"J Exp Med"},{"key":"2021020119155176200_keaa648-B30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4049\/jimmunol.0903505","article-title":"Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150)","volume":"185","author":"Yusuf","year":"2010","journal-title":"J Immunol"},{"key":"2021020119155176200_keaa648-B31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ni.3561","article-title":"Dances with cytokines, featuring TFH cells, IL-21, IL-4 and B cells","volume":"17","author":"B\u00e9langer","year":"2016","journal-title":"Nat Immunol"},{"key":"2021020119155176200_keaa648-B32","doi-asserted-by":"crossref","first-page":"e866","DOI":"10.1097\/MD.0000000000000866","article-title":"Dermatopathic lymphadenopathy with increased IgG4-positive plasma cells","volume":"94","author":"Nakayama","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2021020119155176200_keaa648-B33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/annrheumdis-2016-209139","article-title":"Lesional CD4+ IFN-\u03b3+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis","volume":"76","author":"Maehara","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021020119155176200_keaa648-B34","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1080\/14397595.2018.1436029","article-title":"Stage classification of IgG4-related dacryoadenitis and sialadenitis by the serum cytokine environment","volume":"28","author":"Yamamoto","year":"2018","journal-title":"Mod Rheumatol"},{"key":"2021020119155176200_keaa648-B35","doi-asserted-by":"crossref","first-page":"7696","DOI":"10.1038\/srep07696","article-title":"Interleukin 13-positive mast cells are increased in immunoglobulin G4-related sialadenitis","volume":"5","author":"Takeuchi","year":"2015","journal-title":"Sci Rep"},{"key":"2021020119155176200_keaa648-B36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/rheumatology\/kex171","article-title":"Follicular helper T cells in the pathogenesis of IgG4-related disease","volume":"57","author":"Akiyama","year":"2018","journal-title":"Rheumatology (Oxford"},{"key":"2021020119155176200_keaa648-B37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/all.12342","article-title":"Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy","volume":"69","author":"Mattoo","year":"2014","journal-title":"Allergy"},{"key":"2021020119155176200_keaa648-B38","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease","volume":"138","author":"Mattoo","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2021020119155176200_keaa648-B39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1827.2010.02524.x","article-title":"IgG4-related disease: historical overview and pathology of hematological disorders","volume":"60","author":"Sato","year":"2010","journal-title":"Pathol Int"},{"key":"2021020119155176200_keaa648-B40","doi-asserted-by":"crossref","first-page":"16483","DOI":"10.1038\/s41598-019-52847-6","article-title":"Different clinical patterns of IgG4-RD patients with and without eosinophilia","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci Rep"},{"key":"2021020119155176200_keaa648-B41","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/annrheumdis-2017-212110","article-title":"CC-chemokine ligand 18 is a useful biomarker associated with disease activity in IgG4-related disease","volume":"77","author":"Akiyama","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2021020119155176200_keaa648-B42","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/art.38748","article-title":"DNA microarray analysis of labial salivary glands in IgG4-related disease: comparison with Sj\u00f6gren\u2019s syndrome","volume":"66","author":"Tsuboi","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2021020119155176200_keaa648-B43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clim.2014.10.008","article-title":"Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz\u2019s disease","volume":"156","author":"Furukawa","year":"2015","journal-title":"Clin Immunol"},{"key":"2021020119155176200_keaa648-B44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1189\/jlb.1204712","article-title":"Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes","volume":"78","author":"Schutyser","year":"2005","journal-title":"J Leukoc Biol"},{"key":"2021020119155176200_keaa648-B45","doi-asserted-by":"crossref","first-page":"e2853","DOI":"10.1097\/MD.0000000000002853","article-title":"DNA microarray analysis of submandibular glands in IgG4-related disease indicates a role for MARCO and other innate immune-related proteins","volume":"95","author":"Ohta","year":"2016","journal-title":"Medicine (Baltimore)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/967\/36167972\/keaa648.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/967\/36167972\/keaa648.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T13:06:57Z","timestamp":1696684017000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/2\/967\/5964142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,7]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11,7]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa648","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,11,7]]}}}